TMOD-39. A PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONIST DELAYS GLIOBLASTOMA GROWTH AND INVASION IN A MOUSE MODEL

Glioblastoma Multiforme (GBM) is a diffuse malignant brain tumor with rapid growth and infiltration, high resistance to available therapies, and poor survival rate. The current standard of care only provides patients with an average survival of 12–14 months. Platelet-Activating Factor (PAF) is a str...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Cruz Flores, Valerie, Lasseigne, Lindsay, Menghani, Hemant, Khoutorova, Larissa, Mukherjee, Pranab, Belayev, Ludmila, Bazan, Nicolas
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216758/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.1151
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados